These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 10472332)
1. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. Söling A; Schurr P; Berthold F Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332 [TBL] [Abstract][Full Text] [Related]
2. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA; Neel HB; Strome SE; Roche P Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237 [TBL] [Abstract][Full Text] [Related]
3. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
4. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003 [TBL] [Abstract][Full Text] [Related]
5. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma. Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219 [TBL] [Abstract][Full Text] [Related]
6. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
7. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
8. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
9. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257 [TBL] [Abstract][Full Text] [Related]
10. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148 [TBL] [Abstract][Full Text] [Related]
11. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631 [TBL] [Abstract][Full Text] [Related]
12. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. Rodolfo M; Luksch R; Stockert E; Chen YT; Collini P; Ranzani T; Lombardo C; Dalerba P; Rivoltini L; Arienti F; Fossati-Bellani F; Old LJ; Parmiani G; Castelli C Cancer Res; 2003 Oct; 63(20):6948-55. PubMed ID: 14583496 [TBL] [Abstract][Full Text] [Related]
13. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159 [TBL] [Abstract][Full Text] [Related]
14. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma]. Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059 [TBL] [Abstract][Full Text] [Related]
15. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. Goydos JS; Patel M; Shih W J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121 [TBL] [Abstract][Full Text] [Related]
16. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma. Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer. Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928 [TBL] [Abstract][Full Text] [Related]
19. MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy. Napoletano C; Bellati F; Tarquini E; Tomao F; Taurino F; Spagnoli G; Rughetti A; Muzii L; Nuti M; Benedetti Panici P Am J Obstet Gynecol; 2008 Jan; 198(1):99.e1-7. PubMed ID: 18166319 [TBL] [Abstract][Full Text] [Related]